CAS: 1731-84-6; Methyl Nonanoate

相似化合物

143-08-8 112-05-0 124-19-6

上下游产品

CAS号34957-73-8 9-羟基正壬酸甲酯 | CAS号1931-63-1 9-氧代壬酸甲酯 | CAS号22457-33-6 methyl 9-chloro... | CAS号71194-46-2 methyl 7-chloro... | CAS号63318-22-9 (E)-4-chloro-5-... | CAS号693-54-9 2-癸酮 | CAS号112-05-0 正壬酸 | CAS号292638-85-8 丙烯酸甲酯 | CAS号3338-51-0 nonanehydrazide | CAS号131119-10-3 壬酸香草酯

4-戊烯酸甲酯置于dichloro[1,3-Bis(2,6-Isopropylphenyl)-2-Imidazolidinylidene](Benzylidene) (Tricyclohexylphosphine)Ruthenium(II),Platinum On Carbon,氢气体系中,用 四氢呋喃,甲苯 用作溶剂,20.0 °C,1.0 Mpa 条件下,反应 8.33H,反应生成壬酸甲酯
参考文献: Process For Preparing Mono And Dicarboxylic Acids[fr] Procédé De Préparation D'Acides Mono Et Dicarboxyliques
标题: Process For Preparing Mono And Dicarboxylic Acids[fr] Procédé De Préparation D'Acides Mono Et Dicarboxyliques
摘要:本申请涉及一种根据通式(iv)r1Ooc-(Ch2)M-Ch2Ch2-(Ch2)Y-Coor4(iv)制备二羧酸或二羧酸酯的方法,包括以下步骤:将通式(II)r1Ooc-(Ch2)M-Ch=ch-(Ch2)X-H(II)的烯酸或烯酸酯在存在烯烃交换催化剂的情况下进行交换反应,形成通式(III)r1Ooc-(Ch2)M-Ch=ch-(Ch2)Y-H(III)的长链烯酸或烯酸酯,其中x<="" Div="">

专利信息

专利号:US-5654412-A
优先权日:1996-05-29
标 题:Processes for the synthesis of sialyl Lewisx compounds
发明人：SRIVASTAVA OM; GREGSON JONATHAN M
权利人:GLYCOMED INC
摘要:Disclosed are processes for the chemical synthesis of sialyl Lewisx-Y compounds where Y is -OH, -NHR, -SH, -SR or -OR, and R is an aglycon of at least one carbon atom.

专利号:US-4794176-A
优先权日:1981-06-26
标 题 :Synthesis of tumor antigenic determinant
发明人：LEMIEUX RAYMOND U; RATCLIFFE ROBERT M; BAKER DONALD A
权利人:CHEMBIOMED
摘要:Processes are provided for the synthesis of the human T-antigenic determinant 2-acetamido-2-deoxy-3-O-(β-D-galactopyranosyl)-α-D-galactopyranoside containing an α-O-glycosidically linked bridging arm O--(CH 2 ) n COR. The determinant is coupled to carrier molecules to form artifical T-antigens, and to insoluble supports to form T-immunoadsorbents. The artificial T-antigen is shown to elicit a delayed type hypersensitivity reaction as a diagnostic for the presence of cancer in humans.

专利号:US-4767845-A
优先权日:1980-07-10
标题 :Synthesis of tumor antigenic determinant
发明人：LEMIEUX RAYMOND U; RATCLIFFE ROBERT M; BAKER DONALD A
权利人:CHEMBIOMED LTD
摘要:Processes are provided for the synthesis of the human T-antigenic determinant 2-acetamido-2-deoxy-3-O-(β-D-galactopyranosyl)-α-D-galactopyranoside containing an α-O-glycosidically linked bridging arm O--(CH 2 ) n COR. The determinant is coupled to carrier molecules to form artificial T-antigens, and to insoluble supports to form T-immunoadsorbents. The artifical T-antigen is shown to elicit a delayed type hypersensitivity reaction as a diagnostic for the presence of cancer in humans.

专利号:WO-9616071-A1
优先权日:1994-11-21
标题:PROCESSES FOR THE SYNTHESIS OF 3'-SUBSTITUTED LEWISx COMPOUNDS
发明人：SRIVASTAVA OM; IPPOLITO ROBERT; SRIVASTAVA GEETA; SZWEDA ROMAN; OHUCHI TOSHIO
权利人:GLYCOMED INC; SRIVASTAVA OM; IPPOLITO ROBERT; SRIVASTAVA GEETA; SZWEDA ROMAN; OHUCHI TOSHIO
摘要:Disclosed are processes for the chemical synthesis of 3'-substituted Lewis-OR compounds where R is an aglycon of at least one carbon atom. One particular compound prepared by the processes of this invention is 8-methoxycarbonyl-octyl-2-acetamido-3-O-( alpha -L-fucopyranosyl)-4-O-[3-O-sulfo- beta -D-galactopyranosyl]-2-deoxy- beta -D-glucopyranoside.

专利号:US-5352670-A
优先权日:1991-06-10
标题:Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
发明人：VENOT ANDRE P; UNGER FRANK M; KASHEM MOHAMMED A; BIRD PAUL; MAZID M ABDUL
权利人:ALBERTA RES COUNCIL
摘要:Disclosed are methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides. Specifically, in the disclosed methods, sialyltransferase is activated to transfer an analogue of sialic acid, employed as its CMP-nucleotide derivative, to an oligosaccharide glycoside. The analogue of sialic acid and the oligosaccharide employed in this method are selected to be compatible with the sialyltransferase employed.

专利号:US-2014303363-A1
优先权日:2011-12-09
标题 :Preparation and Use of Isolactosamine and Intermediates therefor
发明人：HEDEROS MARKUS; RISINGER CHRISTIAN; BOUTET JULIEN; DEKANY GYULA
权利人:GLYCOM AS
摘要:The invention relates to providing isolactosamine (Galβ1-3GlcNH 2 , formula 1) and salts thereof in the form of either anomer or mixture thereof, as well as hydrates or solvates of the free base and salts thereof. The synthesis of isolactosamine and its use in the synthesis of lacto-N-biose containing oligosaccharides are also disclosed.